The effects of Ginkgo biloba extract (GBe) on axonal transport, microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats

Environmental Health and Preventive Medicine

Volumn 5, Issue 2, 2000, Pages 53-59

  Kim, J ^a   Yokoyama, K ^a   Araki, S ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Actin; Ginkgo alkaloides; Neurofilament; Neuropathy; Tublin

Indexed keywords

ACTIN; GINKGO BILOBA EXTRACT; GLUCOSE; LIPID PEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG MECHANISM; ENDONEURIUM; MALE; MICROVASCULATURE; NERVE FIBER TRANSPORT; NONHUMAN; OXIDATIVE STRESS; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ANIMALIA; GINKGO BILOBA;

EID: 0033863943     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1265/ehpm.2000.53     Document Type: Article

References (49)

1. Proteins of slow axonal transport in sciatic motorneurones of rats with streptozotocin-induced diabetes or galactosamia
2. Experimental diabetic neuropathy. Effect of ganglioside treatment on axonal transport of cytoskeletal proteins
3. Experimental diabetic neuropathy: Similar changes of slow axonal transport and axonal size in different animal models
4. Slow axonal transport of structural polypeptides in rat, early changes in streptozotocin diabetes, and effect of insulin treatment
5. Axonal transport of the cytoplasmic matrix
6. A proposal for a classification of neuropathies according to their axonal transport abnormalities
7. The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats
8. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotcin diabetic rats
9. Reduced myelinated fiber size correlates with loss of axonal neurofilaments inperipheral nerve of chronically streptozotcin diabetic rats
10. Microangiopathy in human diabetic neuropathy
11. The axonopathy of diabetic neuropathy
12. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
13. Diabetic neuropathy
14. Abnormal microvasculature in diabetic neuropathy
15. Vascular factors in diabetic neuropathy
16. Endoneurial blood flow and oxygen tension in the sciatic nerves in the rats in experimental diabetic neuropathy
17. Sural nerve oxygen tension in diabetes
18. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tenson in non-diabetic and streptozotocin-diabetic rats
19. Pharmacological manipulation of vascular endothelium in non-diabetic and streptozotocin-diabetic rats: Effects on nerve conduction, hypoxic resistance and endoneurial capillarization
20. An animal model of chronic ischemic neuropathy with proliferative changes of nerve microvessel wall
21. Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy
22. Interaction between oxidative stress and r-linolenic acid in impaired neurovascular function of diabetic rats
23. The effects of diatary treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes
24. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy
25. Recent advances in the pathogenesis of diabetic neuropathy
26. Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea
27. Gikgo biloba
28. Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells
29. Myocardium-protective effects of Ginkgo biloba extract (Egb 761) in old rats against acute isobaric hypoxia. An electron microscopic morphometric study. II. Protection of microvascular endothelium
30. Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide
31. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in voluteers
32. Improvement of hemorheology with ginkgo biloba extract. Decreasing a cardiovascular risk factor
33. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids
34. The role of oxidative stress and antioxidant treatment in diabetic neuropathy
35. Neuroprotection by the metabolic antioxidant alpha-lipoic acid
36. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats
37. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: Evidence from experimental studies
38. Early changes in the neuronal cytoskeleton caused by β, β'-iminodipropionitrile: Selective impairment of neurofilament polypeptides
39. Assessment of slow axonal transport in lead-exposed rats
40. Acute endothelial swelling is induced in endoneurial microvessels by ischemia
41. Small vessel disease in progressive in diabetic neuropathy associated with good metabolic control
42. Capillary number and percentage closed in human diabetic sural nerve
43. Endoneurial localisation of microvascular damage in human diabetic neuropathy
44. Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: Effect of ginkgo biloba extract
45. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide
46. Visual evoked potentials and optic nerve histopathology in normal and diabetic rats and effect of ginkgo biloba extract
47. The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-activating factor (PAF)
48. Pharmacological bases of the vascular impact of Ginkgo biloba extract